Lee Troy Schalop bought $100k of LTRN
director at Lantern Pharma Inc.. 48,544 shares at an average of $2.06, traded May 12, 2026, filed May 14, 2026.
Score components
- +15RoleDirector
- +10Trade size$100k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context61% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-023083, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 12, 2026 | POpen-market purchase Common stock, $0.001 par value | +48,544 | $2.06 | $100k | 48,544 | May 14, 2026 |
| May 12, 2026 | POpen-market purchase Common stock purchase warrant (Right to Buy)derivative | -48,544 | $0.00 | $0 | 48,544 | May 14, 2026 |
Related signals
Other insiders at Lantern Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 51Moderate | Lantern Pharma Inc. | D Jeffrey Keyser director | $100k 48,544 shares | +106% | |
| 42Moderate | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $208k 61,613 shares | -30% | |
| 35Weak | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $124k 40,000 shares | -20% | |
| 42Moderate | Lantern Pharma Inc. | Leslie W. Kreis owner | $208k 61,613 shares | -30% | |
| 35Weak | Lantern Pharma Inc. | Leslie W. Kreis owner | $124k 40,000 shares | -20% | |
| 41Moderate | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $168k 56,237 shares | -26% | |
| 41Moderate | Lantern Pharma Inc. | Leslie W. Kreis owner | $168k 56,237 shares | -26% | |
| 42Moderate | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $189k 30,000 shares | -50% | |
| 42Moderate | Lantern Pharma Inc. | Leslie W. Kreis owner | $189k 30,000 shares | -50% | |
| 60Notable | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $676k 144,000 shares | -196% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.